Full Breakdown
Jalen Hurts Blood-Clot Case Sparks NFLPA Call for Investigation
By Drooid · · How we work
Core Event
Philadelphia Eagles quarterback Jalen Hurts was diagnosed with a superficial blood clot in his left calf while the team was in London for its Week 5 matchup against the Jacksonville Jaguars on October 11, 2026. He played, threw for 220 yards and a touchdown, then returned to the United States. A follow-up ultrasound showed the clot had moved, and later testing revealed deep-vein thrombosis and bilateral pulmonary emboli. Hurts was placed on injured reserve and is expected to miss the rest of the season. After the league announced no discipline, the NFL Players Association (NFLPA) demanded a full investigation into his medical care.
Background & Context
- Early October – Hurts reported calf pain after a cleat impact in Week 4.
- Day before the London game – an ultrasound at the Cleveland Clinic in London identified a superficial clot. Team and league doctors cleared him to play.
- October 11 – Hurts played in London; the Eagles later said he slept after a brief hospital stay.
- Mid-week – a second ultrasound in Philadelphia showed clot movement, prompting his removal from the next game.
- Later that week – imaging confirmed deep-vein thrombosis and pulmonary emboli, leading to season-ending treatment with blood thinners.
Official Statements & Responses
- NFL Commissioner Roger Goodell said the league’s protocols were “incredibly good” and that the NFL “welcomes” the NFLPA’s request for a review, emphasizing player health as a priority.
- Dr. Allen Sills, NFL chief medical officer, expressed “complete confidence” in the Eagles’ medical staff and dismissed suggestions of external pressure.
- Jeff Miller, NFL executive vice president for player health and safety, called public speculation “considerable and uninformed” and described the steps taken as “conservative” and patient-focused.
- Nick Sirianni, Eagles head coach, said, “The health of our players is always at the forefront of our mind.”
Criticism & Opposition
The NFLPA’s demand for an independent review challenges the league’s claim that the Eagles acted appropriately. Union officials argue that without a formal investigation, the facts surrounding Hurts’ clearance, the decision to travel, and the progression of his condition cannot be fully verified.
Conflicting Reports & Gaps
- Sleep speculation: Early reports claimed Hurts stayed awake for 36 hours before the London game. The league later clarified he slept for several hours after treatment.
- Investigation status: The NFL said officials were in contact with team doctors and that no discipline would be taken. Goodell said the league “welcomes” an investigation, while the NFLPA says it was not informed of any ongoing review, leaving the scope of the league’s internal assessment unclear.
Data & Statistics
- Initial diagnosis: superficial vein thrombosis in the left calf.
- Subsequent diagnosis: deep-vein thrombosis plus bilateral pulmonary emboli.
- Treatment: anticoagulation therapy; expected recovery of at least three months.
Verbatim Quotes
- “Obviously, there was a medical evaluation, and I think our protocols were incredibly good there,” — Roger Goodell, NFL commissioner
- “The notion that there’s external factors that any of our physicians would put a player in harm’s way — that’s nonsense,” — Dr. Allen Sills, NFL chief medical officer
- “I’m not going into any of that,” — Nick Sirianni, Eagles head coach
What’s Next
The NFLPA may invoke Article 39, Section 5(f) of the collective-bargaining agreement to launch a formal investigation. Two or more neutral physicians would review the case and issue a written report within 60 days, with recommendations for both parties. The outcome could influence future league protocols for blood-clot incidents and international travel.